Best Cannabis Stocks In 2026 Right Now

The Way Cannabis Stocks Are Trading These Companies Could Be Worth Watching

The cannabis industry is once again going through another transitional period. With new laws set to take effect in the US in mid-December, things could ramp up for marijuana stocks. The reason for this could be the rescheduling officially coming into effect. With this, it will benefit many large MSOs and various players in the space. As well as those with the financial backing to enter the sector with some type of strategic partnership.

All of the data shows that the legal cannabis world worldwide is here to stay; even markets like Europe and Canada are thriving. In fact, some of the biggest operators in the space are Canadian and are also publicly traded. Between the new Schedule 3 coming into effect and neighboring global markets growing as well, the future shows untapped potential. Now could be another get-on-board moment for those looking for the best marijuana stocks to buy.

When the initial green rush, as some call it, came into place, many saw the sector as a scary place. Penny stocks that were inside a taboo grey area of the legal framework were allowed but not guaranteed. This left many behind, as some managed to take the risk and, during that period, saw big returns depending on the size of their position. Below are several marijuana stocks to watch that could be worth strategizing and game planning.

Top Marijuana Stocks For People To Make Money

  1. Glass House Brands Inc. (NYSE:GLASF)
  2. Cresco Labs Inc. (OTC:CRLBF)
  3. Verano Holdings Corp. (OTC:VRNO)

Glass House Brands Inc.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States.GLASF

It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. In recent news, the company has reported its Q2 2026 financial earnings.

Q2 2026 Financial Highlights

  • Revenue was $47.0 million, compared to $47.6 million in Q2 last year and $28.6 million in the first quarter 2026.
  • Gross Profit Margin of 34%, compared to 55% in second quarter 2025 and 14% in first quarter 2026.
  • Adjusted EBITDA1 was positive $5.7 million, compared to positive $18.1 million in second quarter 2025 and negative $(4.2) million in first quarter 2026.
  • Operating Cash Flow of positive $0.2 million, compared to $17.7 million in second quarter 2025 and negative $(11.8) million in first quarter 2026.

Cresco Labs Inc.

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. During the first week of August 2026, the company released its Q2 2026 financial results. CRLBF Logo

At this time, the company was able to generate $173 million in revenue and $40 million in adjusted EBITDA.

Words From The Company

“Q2 delivered growth ahead of expectations, with revenue up 15% sequentially to $173 million and Adjusted EBITDA up 20% sequentially. In Pennsylvania, we completed our first quarter operating nine acquired dispensaries and improved their gross profit dollars by 11% before rebranding a single store — demonstrating that our integration model creates measurable value.

[Read More] Top Canadian Cannabis Stocks to Watch in August 2026

Verano Holdings Corp.

Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. VRNOF

The company has also, in recent updates has released its second-quarter financial report.

[Read More] 3 Marijuana Stocks For Investors To Consider

Second Quarter 2026 Financial Highlights

  • Revenues, net of discounts, were $218 million, an increase of 5% versus the prior quarter, and an increase of 8% year-over-year.
  • Gross profit was $100 million or 46% of revenue.
  • SG&A expenses of $92 million or 42% of revenue.
  • Net Loss of $(13) million or (6)% of revenue.
  • Adjusted EBITDA1 of $51 million or 24% of revenue.
  • Net cash provided by operating activities of $31 million.
  • Capital expenditures of $12 million.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like